David Schmidt - 14 Aug 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Reporting relationship: Director
Issuer ticker: ASTH
Reported as of: 14 Aug 2024
Net transaction value: -$485,382
SEC form: 4
Accepted by SEC: 16 Aug 2024, 16:15:10 UTC
Prior SEC filing: 14 Aug 2024
Next SEC filing: 13 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ John Vong, as Attorney-in-Fact

Key filing fact

David Schmidt filed Form 4 for Astrana Health, Inc. (ASTH) on 16 Aug 2024.

Key facts

This page summarizes David Schmidt's Form 4 filing for Astrana Health, Inc. (ASTH).
5 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 16 Aug 2024, 16:15.

Change

Previous filing in this sequence was filed on 14 Aug 2024.
Current net transaction value: -$485,382.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASTH transaction

Common Stock

Options Exercise

Transaction value: $168,850
Shares: +11,000
Change %: +118%
Price: $15.35^*
Shares after: 20,314
Date: 14 Aug 2024
Ownership: Direct

ASTH transaction

Common Stock

Options Exercise

Transaction value: $62,760
Shares: +3,409
Change %: +17%
Price: $18.41^*
Shares after: 23,723
Date: 14 Aug 2024
Ownership: Direct

ASTH transaction

Common Stock

Disposed to Issuer

Transaction value: $716,992
Shares: -14,409
Change %: -61%
Price: $49.76
Shares after: 9,314
Date: 16 Aug 2024
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASTH transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -11,000
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,000
Exercise price: $15.35
Footnotes: F3

ASTH transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -3,409
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 14 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,409
Exercise price: $18.41
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These shares were repurchased by the Issuer.

Footnote F2

Includes 5,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.

Footnote F3

These stock options were fully vested and exercisable.